Anti-Idiotypic Antibodies in Immune Regulation and Disease: Therapeutic Promise for Next-Generation Vaccines.

Vaccines (Basel) · 2025 · PMC12737560 · PMID 41441690

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

It has been reported that following SARS-CoV-2 infection, not only are antibodies against the SARS-CoV-2 S-protein produced, but also autoantibodies against ACE2, which may be significant for the development of long COVID after SARS-CoV-2 infection [ 96 , 97 , 98 , 99 , 100 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.